Stifel Financial’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,766
Closed -$18.6K 3416
2022
Q4
$18.6K Sell
10,766
-1,740
-14% -$3.01K ﹤0.01% 3249
2022
Q3
$25K Sell
12,506
-13,722
-52% -$27.4K ﹤0.01% 3222
2022
Q2
$19K Sell
26,228
-11,500
-30% -$8.33K ﹤0.01% 3282
2022
Q1
$328K Buy
37,728
+7,842
+26% +$68.2K ﹤0.01% 2827
2021
Q4
$479K Sell
29,886
-17,430
-37% -$279K ﹤0.01% 2612
2021
Q3
$871K Sell
47,316
-1,753
-4% -$32.3K ﹤0.01% 2203
2021
Q2
$685K Buy
49,069
+500
+1% +$6.98K ﹤0.01% 2389
2021
Q1
$714K Sell
48,569
-419
-0.9% -$6.16K ﹤0.01% 2237
2020
Q4
$950K Sell
48,988
-1,280
-3% -$24.8K ﹤0.01% 1883
2020
Q3
$561K Buy
50,268
+7,481
+17% +$83.5K ﹤0.01% 2011
2020
Q2
$579K Sell
42,787
-1,209
-3% -$16.4K ﹤0.01% 1941
2020
Q1
$355K Buy
43,996
+13,969
+47% +$113K ﹤0.01% 2081
2019
Q4
$289K Buy
30,027
+17,078
+132% +$164K ﹤0.01% 2548
2019
Q3
$137K Buy
+12,949
New +$137K ﹤0.01% 2726